cautious on biogen's alzheimer’s drug due to uncertainty around cost, reimbursement, access: wedbush
Published 3 years ago • 456 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
3:00
biogen shares drop as big clinics say they won't administer controversial alzheimer's drug
-
4:05
biogen shares surge on upbeat alzheimer's study results
-
6:10
the science behind aduhelm, a controversial new alzheimer’s drug | wsj
-
6:51
biogen has breakthrough alzheimer's drug
-
2:10
biogen analyst sees no clear growth driver to replace alzheimer's drug
-
3:58
eisai's alzheimer's drug reduces cognitive decline by 27% in trial patients
-
5:04
this analyst breaks down the bull case for biogen's alzheimer's drug
-
33:06
the implications of fda's decision on aducanumab | braintalk | being patient
-
2:12
biogen to ship alzheimer’s drug in two weeks
-
4:16
a second chance for injured brains - futuris
-
2:20
undergraduate research: heat stress and tomato plants
-
1:12
isolating the protein of interest in abe
-
1:19
algae is a superfood and the most nutrient dense food of them all.
-
2:59
why is biotech exploding now?
-
37:02
𝐇𝐚𝐠𝐨 𝐄𝐧𝐞𝐫𝐠𝐞𝐭𝐢𝐜𝐬: 𝐂𝐨𝐧𝐯𝐞𝐫𝐭𝐢𝐧𝐠 𝐖𝐚𝐬𝐭𝐞 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬 𝐢𝐧𝐭𝐨 𝐁𝐢𝐨𝐜𝐡𝐚𝐫 𝐚𝐧𝐝 𝐇𝐲𝐝𝐫𝐨𝐠𝐞𝐧
-
1:37
researching biofuels
-
3:02
brilliant minds - molecular biologist ulf andersson ørom | tomorrow today
-
32:24
illustrating the complex microbial world within us
-
12:35
stembiosys
-
4:01
b.i.o.logically hazardous material
-
2:11
the scientists of tomorrow: welmoed van zuiden